

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine secretion (GO:0090197) | 8.20113747 |
| 2 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 6.89292326 |
| 3 | macrophage activation involved in immune response (GO:0002281) | 6.78034349 |
| 4 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 6.67948698 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.54227896 |
| 6 | negative regulation of granulocyte differentiation (GO:0030853) | 6.34628468 |
| 7 | regulation of chemokine secretion (GO:0090196) | 6.28783469 |
| 8 | eosinophil chemotaxis (GO:0048245) | 6.26556376 |
| 9 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 6.00007539 |
| 10 | macrophage activation (GO:0042116) | 5.89695807 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.83231262 |
| 12 | regulation of mononuclear cell migration (GO:0071675) | 5.73445494 |
| 13 | adenosine receptor signaling pathway (GO:0001973) | 5.73104973 |
| 14 | eosinophil migration (GO:0072677) | 5.65174832 |
| 15 | glycosphingolipid catabolic process (GO:0046479) | 5.51861305 |
| 16 | oligosaccharide catabolic process (GO:0009313) | 5.49223764 |
| 17 | regulation of hypersensitivity (GO:0002883) | 5.47791852 |
| 18 | purinergic receptor signaling pathway (GO:0035587) | 5.29266818 |
| 19 | negative regulation of norepinephrine secretion (GO:0010700) | 5.00747274 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.97163325 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.97163325 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.97163325 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.97163325 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.97163325 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.97163325 |
| 26 | glycolipid catabolic process (GO:0019377) | 4.95049263 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.87493084 |
| 28 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 4.65022320 |
| 29 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.64345360 |
| 30 | positive regulation of mast cell degranulation (GO:0043306) | 4.64345360 |
| 31 | keratan sulfate catabolic process (GO:0042340) | 4.58575568 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 4.56195644 |
| 33 | chondroitin sulfate catabolic process (GO:0030207) | 4.51461722 |
| 34 | phagocytosis, recognition (GO:0006910) | 4.49363580 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.48689780 |
| 36 | phagocytosis, engulfment (GO:0006911) | 4.46911745 |
| 37 | ceramide catabolic process (GO:0046514) | 4.41454333 |
| 38 | positive regulation of interferon-alpha production (GO:0032727) | 4.26461077 |
| 39 | positive regulation of mast cell activation (GO:0033005) | 4.25256847 |
| 40 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.16594140 |
| 41 | negative regulation of tissue remodeling (GO:0034104) | 4.16593087 |
| 42 | amino sugar catabolic process (GO:0046348) | 4.13593513 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 4.12591838 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.07578447 |
| 45 | hyaluronan catabolic process (GO:0030214) | 4.05692072 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 4.05210871 |
| 47 | regulation of cholesterol storage (GO:0010885) | 4.01482664 |
| 48 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.88918520 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.87322739 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.86760533 |
| 51 | positive regulation of leukocyte degranulation (GO:0043302) | 3.81472916 |
| 52 | positive regulation of antigen processing and presentation (GO:0002579) | 3.78680629 |
| 53 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.76949686 |
| 54 | regulation of macrophage chemotaxis (GO:0010758) | 3.75508019 |
| 55 | negative regulation of bone resorption (GO:0045779) | 3.74190093 |
| 56 | neutrophil activation involved in immune response (GO:0002283) | 3.73466665 |
| 57 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.72107179 |
| 58 | N-acetylneuraminate metabolic process (GO:0006054) | 3.70839878 |
| 59 | B cell mediated immunity (GO:0019724) | 3.70236192 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 3.69038149 |
| 61 | negative regulation of interleukin-6 production (GO:0032715) | 3.63464953 |
| 62 | monocyte differentiation (GO:0030224) | 3.58380048 |
| 63 | tolerance induction (GO:0002507) | 3.57963230 |
| 64 | macrophage chemotaxis (GO:0048246) | 3.54938409 |
| 65 | detection of external biotic stimulus (GO:0098581) | 3.53694972 |
| 66 | cellular response to ethanol (GO:0071361) | 3.51809638 |
| 67 | I-kappaB phosphorylation (GO:0007252) | 3.50384751 |
| 68 | ruffle organization (GO:0031529) | 3.47332758 |
| 69 | macrophage differentiation (GO:0030225) | 3.46292149 |
| 70 | cyclooxygenase pathway (GO:0019371) | 3.43598026 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39328142 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37762512 |
| 73 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.37662908 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.32300022 |
| 75 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.31492343 |
| 76 | monocyte chemotaxis (GO:0002548) | 3.28119251 |
| 77 | regulation of monocyte chemotaxis (GO:0090025) | 3.27568686 |
| 78 | cellular extravasation (GO:0045123) | 3.26250102 |
| 79 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.26061574 |
| 80 | T-helper 1 type immune response (GO:0042088) | 3.24608990 |
| 81 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.23144776 |
| 82 | lysosome organization (GO:0007040) | 3.22891070 |
| 83 | lytic vacuole organization (GO:0080171) | 3.22891070 |
| 84 | adaptation of signaling pathway (GO:0023058) | 3.21010058 |
| 85 | myeloid leukocyte activation (GO:0002274) | 3.17375175 |
| 86 | Rac protein signal transduction (GO:0016601) | 3.15040051 |
| 87 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.14302564 |
| 88 | regulation of granulocyte differentiation (GO:0030852) | 3.13706863 |
| 89 | detection of biotic stimulus (GO:0009595) | 3.11571518 |
| 90 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.11283889 |
| 91 | negative regulation of cell killing (GO:0031342) | 3.11147800 |
| 92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11147800 |
| 93 | membrane invagination (GO:0010324) | 3.09604243 |
| 94 | adhesion of symbiont to host cell (GO:0044650) | 3.08689370 |
| 95 | virion attachment to host cell (GO:0019062) | 3.08689370 |
| 96 | positive regulation of macrophage cytokine production (GO:0060907) | 3.08207984 |
| 97 | negative regulation of multicellular organism growth (GO:0040015) | 3.08033268 |
| 98 | detection of other organism (GO:0098543) | 3.07831111 |
| 99 | response to cholesterol (GO:0070723) | 3.07239577 |
| 100 | negative regulation of B cell proliferation (GO:0030889) | 3.05192987 |
| 101 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.04639232 |
| 102 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.03894281 |
| 103 | mannose metabolic process (GO:0006013) | 3.03790894 |
| 104 | sodium-independent organic anion transport (GO:0043252) | 3.03305907 |
| 105 | glial cell migration (GO:0008347) | 3.03270128 |
| 106 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.03137476 |
| 107 | regulation of leukocyte degranulation (GO:0043300) | 3.02681828 |
| 108 | barbed-end actin filament capping (GO:0051016) | 3.02261503 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.02209875 |
| 110 | ganglioside metabolic process (GO:0001573) | 3.02207078 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 2.98927513 |
| 112 | positive regulation of phagocytosis (GO:0050766) | 2.97885338 |
| 113 | response to host (GO:0075136) | 2.95891687 |
| 114 | response to host defenses (GO:0052200) | 2.95891687 |
| 115 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95891687 |
| 116 | negative regulation of bone remodeling (GO:0046851) | 2.95818078 |
| 117 | negative regulation of catecholamine secretion (GO:0033604) | 2.95442461 |
| 118 | adhesion of symbiont to host (GO:0044406) | 2.95212701 |
| 119 | germ cell migration (GO:0008354) | 2.95205996 |
| 120 | positive regulation of type 2 immune response (GO:0002830) | 2.94205269 |
| 121 | histamine secretion (GO:0001821) | 2.94126427 |
| 122 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91894570 |
| 123 | granulocyte chemotaxis (GO:0071621) | 2.91637611 |
| 124 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86097192 |
| 125 | response to host immune response (GO:0052572) | 2.85532186 |
| 126 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85532186 |
| 127 | complement activation, alternative pathway (GO:0006957) | 2.84049155 |
| 128 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.83156995 |
| 129 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82822444 |
| 130 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.82374576 |
| 131 | positive regulation of interferon-beta production (GO:0032728) | 2.81686895 |
| 132 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81120913 |
| 133 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.80740475 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.80184199 |
| 135 | granulocyte migration (GO:0097530) | 2.80067441 |
| 136 | regulation of B cell differentiation (GO:0045577) | 2.77635631 |
| 137 | regulation of type 2 immune response (GO:0002828) | 2.77459877 |
| 138 | regulation of T cell tolerance induction (GO:0002664) | 2.76588379 |
| 139 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.76272610 |
| 140 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.76272610 |
| 141 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75674632 |
| 142 | positive regulation of cholesterol efflux (GO:0010875) | 2.75288470 |
| 143 | pinocytosis (GO:0006907) | 2.74682879 |
| 144 | B cell receptor signaling pathway (GO:0050853) | 2.74015751 |
| 145 | immunoglobulin mediated immune response (GO:0016064) | 2.73446364 |
| 146 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73015174 |
| 147 | positive regulation of acute inflammatory response (GO:0002675) | 2.72711800 |
| 148 | negative regulation of osteoclast differentiation (GO:0045671) | 2.72541758 |
| 149 | response to peptidoglycan (GO:0032494) | 2.71551583 |
| 150 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.69851417 |
| 151 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.69679869 |
| 152 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.68478501 |
| 153 | cellular response to interferon-gamma (GO:0071346) | 2.68321994 |
| 154 | apoptotic cell clearance (GO:0043277) | 2.67720368 |
| 155 | regulation of monocyte differentiation (GO:0045655) | 2.67149369 |
| 156 | granulocyte activation (GO:0036230) | 2.67122563 |
| 157 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.66037612 |
| 158 | negative regulation of macrophage differentiation (GO:0045650) | 2.65626500 |
| 159 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 10.4252156 |
| 160 | microglial cell activation (GO:0001774) | 10.2866796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.99222902 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.28343072 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.50541809 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.16991616 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.57047908 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.18648636 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.09773804 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93667029 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.92164903 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72716297 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.62482992 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.56263911 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54755556 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.51887549 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.46989518 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.45015720 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.36042251 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01982238 |
| 19 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.94243126 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90378962 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90053602 |
| 22 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.83959523 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82925333 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80084639 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.78697089 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78113555 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76487901 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.74553269 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72224745 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69099054 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62120658 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57862580 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55653170 |
| 34 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.52097386 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51468138 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50449675 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49539168 |
| 38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.47326710 |
| 39 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44470953 |
| 40 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.44037147 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42932752 |
| 42 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37560258 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33854525 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29396856 |
| 45 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28606299 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28428602 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28139941 |
| 48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26059394 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25117450 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20972805 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18824016 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18216883 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17349221 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.16013782 |
| 55 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15647141 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14027647 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13387990 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10670236 |
| 59 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08975816 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06461332 |
| 61 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05712087 |
| 62 | MAF_26560356_Chip-Seq_TH1_Human | 1.04377643 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03577646 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03261338 |
| 65 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.02982519 |
| 66 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.02982519 |
| 67 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.02982519 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02709426 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02635108 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01354996 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99828979 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99620348 |
| 73 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97352839 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97300715 |
| 75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97099213 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96302506 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95412253 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 0.89772469 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88526910 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88315070 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88126651 |
| 82 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87863767 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86166193 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86014833 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85558064 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84807063 |
| 87 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.83997185 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83817459 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82949569 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 0.82719403 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82368087 |
| 92 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.81671332 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81581897 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81477592 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81425438 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80525038 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80468980 |
| 98 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79958805 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78683137 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78676573 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78436354 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76362078 |
| 103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.75628099 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.75055698 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74982805 |
| 106 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74527621 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74459725 |
| 108 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72233705 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72209680 |
| 110 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.72115643 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.71674426 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71537326 |
| 113 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.71427100 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71427100 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71379989 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71379989 |
| 117 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71362482 |
| 118 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.71194267 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.70853684 |
| 120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.70592296 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.69885784 |
| 122 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.69634035 |
| 123 | VDR_22108803_ChIP-Seq_LS180_Human | 0.69471752 |
| 124 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.69137558 |
| 125 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.68078079 |
| 126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.67907053 |
| 127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.67403038 |
| 128 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.67226467 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66732653 |
| 130 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66561085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 5.70666807 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 5.50649366 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.51842230 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.96988317 |
| 5 | MP0005671_abnormal_response_to | 3.68854803 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.49319566 |
| 7 | MP0003690_abnormal_glial_cell | 3.46895676 |
| 8 | MP0005464_abnormal_platelet_physiology | 3.22642242 |
| 9 | MP0003303_peritoneal_inflammation | 3.01807971 |
| 10 | MP0009840_abnormal_foam_cell | 3.00131977 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.80288182 |
| 12 | MP0003075_altered_response_to | 2.54056000 |
| 13 | MP0002419_abnormal_innate_immunity | 2.52127141 |
| 14 | MP0003724_increased_susceptibility_to | 2.25497539 |
| 15 | MP0008004_abnormal_stomach_pH | 2.25377161 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.24183287 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.18766512 |
| 18 | MP0004883_abnormal_blood_vessel | 2.10758053 |
| 19 | MP0003252_abnormal_bile_duct | 2.06662029 |
| 20 | MP0001800_abnormal_humoral_immune | 2.02532774 |
| 21 | MP0003436_decreased_susceptibility_to | 1.98586554 |
| 22 | MP0002723_abnormal_immune_serum | 1.97323846 |
| 23 | MP0001819_abnormal_immune_cell | 1.75712196 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.72235663 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.69699085 |
| 26 | MP0003195_calcinosis | 1.69644744 |
| 27 | MP0005166_decreased_susceptibility_to | 1.69225377 |
| 28 | MP0001851_eye_inflammation | 1.69217662 |
| 29 | MP0005025_abnormal_response_to | 1.65144122 |
| 30 | MP0002928_abnormal_bile_duct | 1.64420393 |
| 31 | MP0000343_altered_response_to | 1.63914344 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.63748773 |
| 33 | MP0002254_reproductive_system_inflammat | 1.60889102 |
| 34 | MP0003279_aneurysm | 1.56369003 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.54176731 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.54067637 |
| 37 | MP0003329_amyloid_beta_deposits | 1.51315440 |
| 38 | MP0005310_abnormal_salivary_gland | 1.49688777 |
| 39 | MP0002090_abnormal_vision | 1.48591645 |
| 40 | MP0003045_fibrosis | 1.45200639 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.45095852 |
| 42 | MP0000920_abnormal_myelination | 1.44679107 |
| 43 | MP0005451_abnormal_body_composition | 1.43918879 |
| 44 | MP0009785_altered_susceptibility_to | 1.43480809 |
| 45 | MP0005387_immune_system_phenotype | 1.38925311 |
| 46 | MP0001790_abnormal_immune_system | 1.38925311 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.38227986 |
| 48 | MP0008469_abnormal_protein_level | 1.37712931 |
| 49 | MP0005360_urolithiasis | 1.33512954 |
| 50 | MP0004510_myositis | 1.32815276 |
| 51 | MP0008007_abnormal_cellular_replicative | 1.31761371 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.30450461 |
| 53 | MP0002405_respiratory_system_inflammati | 1.29731475 |
| 54 | MP0005670_abnormal_white_adipose | 1.29109479 |
| 55 | MP0005365_abnormal_bile_salt | 1.28189530 |
| 56 | MP0001915_intracranial_hemorrhage | 1.27196083 |
| 57 | MP0000716_abnormal_immune_system | 1.24294761 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.19874883 |
| 59 | MP0000249_abnormal_blood_vessel | 1.18498601 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.15968351 |
| 61 | MP0004130_abnormal_muscle_cell | 1.15601690 |
| 62 | MP0003633_abnormal_nervous_system | 1.15024701 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.14459970 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.14459970 |
| 65 | MP0002139_abnormal_hepatobiliary_system | 1.13724516 |
| 66 | MP0005164_abnormal_response_to | 1.11327263 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.10524766 |
| 68 | MP0000685_abnormal_immune_system | 1.10286447 |
| 69 | MP0000767_abnormal_smooth_muscle | 1.08481496 |
| 70 | MP0005165_increased_susceptibility_to | 1.05464987 |
| 71 | MP0002398_abnormal_bone_marrow | 1.02943819 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 1.01593435 |
| 73 | MP0001853_heart_inflammation | 0.98951136 |
| 74 | MP0002722_abnormal_immune_system | 0.98944784 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 0.97108832 |
| 76 | MP0003632_abnormal_nervous_system | 0.96477537 |
| 77 | MP0003828_pulmonary_edema | 0.95561491 |
| 78 | MP0002429_abnormal_blood_cell | 0.94084633 |
| 79 | MP0008874_decreased_physiological_sensi | 0.91796083 |
| 80 | MP0008873_increased_physiological_sensi | 0.91011533 |
| 81 | MP0005174_abnormal_tail_pigmentation | 0.89314387 |
| 82 | MP0004947_skin_inflammation | 0.83416728 |
| 83 | MP0009115_abnormal_fat_cell | 0.82942114 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.79832128 |
| 85 | MP0002166_altered_tumor_susceptibility | 0.79684279 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.77918488 |
| 87 | MP0000604_amyloidosis | 0.76933376 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.76336324 |
| 89 | MP0004484_altered_response_of | 0.75851947 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75593552 |
| 91 | MP0003634_abnormal_glial_cell | 0.75516411 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.75270420 |
| 93 | MP0001873_stomach_inflammation | 0.75246527 |
| 94 | MP0002971_abnormal_brown_adipose | 0.74505988 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.74175347 |
| 96 | MP0006054_spinal_hemorrhage | 0.71686802 |
| 97 | MP0002736_abnormal_nociception_after | 0.71114775 |
| 98 | MP0000858_altered_metastatic_potential | 0.70574348 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.69841976 |
| 100 | MP0009278_abnormal_bone_marrow | 0.69814183 |
| 101 | MP0005390_skeleton_phenotype | 0.69242327 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.69175681 |
| 103 | MP0009764_decreased_sensitivity_to | 0.67414439 |
| 104 | MP0005647_abnormal_sex_gland | 0.65791482 |
| 105 | MP0001542_abnormal_bone_strength | 0.64387730 |
| 106 | MP0002933_joint_inflammation | 0.64344679 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.63893875 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.63619427 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.63401824 |
| 110 | MP0005334_abnormal_fat_pad | 0.62315337 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.62222307 |
| 112 | MP0008260_abnormal_autophagy | 0.61891045 |
| 113 | MP0000609_abnormal_liver_physiology | 0.61588863 |
| 114 | MP0005197_abnormal_uvea_morphology | 0.61242231 |
| 115 | MP0000371_diluted_coat_color | 0.60756563 |
| 116 | MP0005408_hypopigmentation | 0.60671682 |
| 117 | MP0003795_abnormal_bone_structure | 0.57907532 |
| 118 | MP0002064_seizures | 0.57485985 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.57477070 |
| 120 | MP0009763_increased_sensitivity_to | 0.57168952 |
| 121 | MP0002135_abnormal_kidney_morphology | 0.56502501 |
| 122 | MP0002006_tumorigenesis | 0.55657361 |
| 123 | MP0000569_abnormal_digit_pigmentation | 0.54443354 |
| 124 | MP0003631_nervous_system_phenotype | 0.54248720 |
| 125 | MP0003763_abnormal_thymus_physiology | 0.48236282 |
| 126 | MP0003448_altered_tumor_morphology | 0.47930289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glomerulonephritis (HP:0000099) | 9.42894205 |
| 2 | Complement deficiency (HP:0004431) | 7.62390161 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.84319700 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.84319700 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 6.84319700 |
| 6 | Abnormality of complement system (HP:0005339) | 5.63476695 |
| 7 | Arterial tortuosity (HP:0005116) | 5.25085783 |
| 8 | Retinal atrophy (HP:0001105) | 4.69975714 |
| 9 | Nephritis (HP:0000123) | 4.64592851 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.60974536 |
| 11 | Vascular tortuosity (HP:0004948) | 4.58433447 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 4.56454303 |
| 13 | Urethral obstruction (HP:0000796) | 4.53097818 |
| 14 | Recurrent abscess formation (HP:0002722) | 4.33534182 |
| 15 | Mutism (HP:0002300) | 4.32260252 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 4.31268205 |
| 17 | Cerebral aneurysm (HP:0004944) | 4.24976427 |
| 18 | Disinhibition (HP:0000734) | 4.13452935 |
| 19 | Axonal loss (HP:0003447) | 3.86288560 |
| 20 | Dysostosis multiplex (HP:0000943) | 3.70638323 |
| 21 | Chronic diarrhea (HP:0002028) | 3.68349319 |
| 22 | Orthostatic hypotension (HP:0001278) | 3.62159250 |
| 23 | Agnosia (HP:0010524) | 3.58209499 |
| 24 | Upper motor neuron abnormality (HP:0002127) | 3.46990146 |
| 25 | Hematochezia (HP:0002573) | 3.43106486 |
| 26 | Loss of speech (HP:0002371) | 3.40321684 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.38311715 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.37970226 |
| 29 | Pustule (HP:0200039) | 3.35747037 |
| 30 | Aortic aneurysm (HP:0004942) | 3.34683918 |
| 31 | Premature loss of primary teeth (HP:0006323) | 3.21555652 |
| 32 | Gingivitis (HP:0000230) | 3.19875450 |
| 33 | Progressive neurologic deterioration (HP:0002344) | 3.18327852 |
| 34 | Abnormal platelet function (HP:0011869) | 3.12754248 |
| 35 | Impaired platelet aggregation (HP:0003540) | 3.12754248 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 3.08586342 |
| 37 | Amyloidosis (HP:0011034) | 3.01368039 |
| 38 | Partial duplication of thumb phalanx (HP:0009944) | 2.96069349 |
| 39 | Disproportionate tall stature (HP:0001519) | 2.88278269 |
| 40 | Colitis (HP:0002583) | 2.85352753 |
| 41 | Neuronal loss in central nervous system (HP:0002529) | 2.82713818 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79110210 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79110210 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.78378979 |
| 45 | Striae distensae (HP:0001065) | 2.71140524 |
| 46 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.68784880 |
| 47 | Prostate neoplasm (HP:0100787) | 2.68413706 |
| 48 | Split foot (HP:0001839) | 2.66071489 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.65084509 |
| 50 | Intestinal atresia (HP:0011100) | 2.62809333 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.61777626 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61777626 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.58222854 |
| 54 | Aortic dissection (HP:0002647) | 2.58132448 |
| 55 | Inappropriate behavior (HP:0000719) | 2.54633574 |
| 56 | Partial duplication of the phalanx of hand (HP:0009999) | 2.54145423 |
| 57 | Rectal fistula (HP:0100590) | 2.48632805 |
| 58 | Rectovaginal fistula (HP:0000143) | 2.48632805 |
| 59 | Nuclear cataract (HP:0100018) | 2.48197889 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45145922 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45145922 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45145922 |
| 63 | Arnold-Chiari malformation (HP:0002308) | 2.43564674 |
| 64 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41944466 |
| 65 | Intestinal fistula (HP:0100819) | 2.39814714 |
| 66 | Myositis (HP:0100614) | 2.34855635 |
| 67 | Apathy (HP:0000741) | 2.32387318 |
| 68 | Recurrent skin infections (HP:0001581) | 2.30089800 |
| 69 | Pathologic fracture (HP:0002756) | 2.29323835 |
| 70 | Cardiomegaly (HP:0001640) | 2.28865745 |
| 71 | Recurrent fungal infections (HP:0002841) | 2.28790944 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.23501133 |
| 73 | Diminished motivation (HP:0000745) | 2.21001477 |
| 74 | Polygenic inheritance (HP:0010982) | 2.19548948 |
| 75 | Urinary incontinence (HP:0000020) | 2.17247706 |
| 76 | Purpura (HP:0000979) | 2.16222453 |
| 77 | Erectile abnormalities (HP:0100639) | 2.14983851 |
| 78 | Hemoptysis (HP:0002105) | 2.14651501 |
| 79 | Lower limb asymmetry (HP:0100559) | 2.14303709 |
| 80 | Vaginal fistula (HP:0004320) | 2.10797940 |
| 81 | Retrobulbar optic neuritis (HP:0100654) | 2.10219180 |
| 82 | Optic neuritis (HP:0100653) | 2.10219180 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09742451 |
| 84 | Spontaneous hematomas (HP:0007420) | 2.08339608 |
| 85 | Neurofibrillary tangles (HP:0002185) | 2.07915674 |
| 86 | Joint hemorrhage (HP:0005261) | 2.05224708 |
| 87 | Esophageal neoplasm (HP:0100751) | 2.04418419 |
| 88 | Neoplasm of head and neck (HP:0012288) | 2.04418419 |
| 89 | Mitral valve prolapse (HP:0001634) | 2.04262197 |
| 90 | J-shaped sella turcica (HP:0002680) | 2.03592765 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.03248665 |
| 92 | Dementia (HP:0000726) | 2.02512851 |
| 93 | Progressive visual loss (HP:0000529) | 2.02418992 |
| 94 | Abnormality of the basal ganglia (HP:0002134) | 2.02398927 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 2.02014269 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02014269 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 2.00211222 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 10.6474858 |
| 99 | Periodontitis (HP:0000704) | 1.99438065 |
| 100 | Abnormality of the periventricular white matter (HP:0002518) | 1.99096890 |
| 101 | Memory impairment (HP:0002354) | 1.98394523 |
| 102 | Gastrointestinal inflammation (HP:0004386) | 1.97899545 |
| 103 | Abnormality of macrophages (HP:0004311) | 1.97724504 |
| 104 | Pulmonary infiltrates (HP:0002113) | 1.97675913 |
| 105 | Basal ganglia calcification (HP:0002135) | 1.96665668 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 1.96325080 |
| 107 | Increased CSF protein (HP:0002922) | 1.94577156 |
| 108 | Orchitis (HP:0100796) | 1.93966025 |
| 109 | Stomatitis (HP:0010280) | 1.93715880 |
| 110 | Spinal muscular atrophy (HP:0007269) | 1.91674956 |
| 111 | Camptodactyly of toe (HP:0001836) | 1.88564890 |
| 112 | Peripheral demyelination (HP:0011096) | 1.88415126 |
| 113 | Global brain atrophy (HP:0002283) | 1.87682061 |
| 114 | Meningitis (HP:0001287) | 1.86807045 |
| 115 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.85990791 |
| 116 | Myocardial infarction (HP:0001658) | 1.85945718 |
| 117 | Epistaxis (HP:0000421) | 1.85593611 |
| 118 | Spondylolisthesis (HP:0003302) | 1.83546642 |
| 119 | Prolonged bleeding time (HP:0003010) | 1.82194710 |
| 120 | Cheilitis (HP:0100825) | 1.82001048 |
| 121 | Obstructive lung disease (HP:0006536) | 1.81923821 |
| 122 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81923821 |
| 123 | Clumsiness (HP:0002312) | 1.75916545 |
| 124 | Malnutrition (HP:0004395) | 1.75801164 |
| 125 | Exotropia (HP:0000577) | 1.75341017 |
| 126 | Polyneuropathy (HP:0001271) | 1.74304808 |
| 127 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.69690621 |
| 128 | Albinism (HP:0001022) | 1.69642175 |
| 129 | Metaphyseal irregularity (HP:0003025) | 1.68775035 |
| 130 | IgM deficiency (HP:0002850) | 1.67522890 |
| 131 | Postural instability (HP:0002172) | 1.67148165 |
| 132 | Conjunctival telangiectasia (HP:0000524) | 1.65160284 |
| 133 | Urticaria (HP:0001025) | 1.63067868 |
| 134 | Bone cyst (HP:0012062) | 1.62173508 |
| 135 | Petechiae (HP:0000967) | 1.61838313 |
| 136 | Thick nail (HP:0001805) | 1.61394720 |
| 137 | Personality changes (HP:0000751) | 1.60947656 |
| 138 | Bone pain (HP:0002653) | 1.59671776 |
| 139 | Abnormal large intestine physiology (HP:0012700) | 1.56777364 |
| 140 | Cellulitis (HP:0100658) | 1.56067102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 8.06658768 |
| 2 | PDK2 | 4.95480902 |
| 3 | GRK7 | 4.03551947 |
| 4 | MAPK15 | 3.95385984 |
| 5 | CSF1R | 3.21654577 |
| 6 | TYK2 | 2.64545602 |
| 7 | NEK9 | 2.49046808 |
| 8 | NTRK2 | 2.07770716 |
| 9 | MAP3K14 | 2.06536215 |
| 10 | TSSK6 | 2.05599447 |
| 11 | MAPK12 | 2.04333289 |
| 12 | BLK | 1.94613819 |
| 13 | PAK4 | 1.88727010 |
| 14 | NEK6 | 1.86378223 |
| 15 | IRAK3 | 1.85403748 |
| 16 | RIPK4 | 1.79669299 |
| 17 | MAPK7 | 1.76095877 |
| 18 | TBK1 | 1.68198845 |
| 19 | ACVR1B | 1.60662440 |
| 20 | MATK | 1.59301820 |
| 21 | JAK3 | 1.56012946 |
| 22 | TXK | 1.51805434 |
| 23 | PKN2 | 1.51707913 |
| 24 | JAK1 | 1.49661017 |
| 25 | STK10 | 1.47665356 |
| 26 | ERN1 | 1.40564168 |
| 27 | EPHB1 | 1.36075845 |
| 28 | MOS | 1.35311307 |
| 29 | ZAP70 | 1.33991464 |
| 30 | IKBKB | 1.33413124 |
| 31 | MAP4K1 | 1.31496643 |
| 32 | IRAK4 | 1.30789653 |
| 33 | CLK1 | 1.30653941 |
| 34 | CDC42BPA | 1.25705146 |
| 35 | BMPR2 | 1.21407788 |
| 36 | MAP3K3 | 1.14551818 |
| 37 | CSK | 1.09236427 |
| 38 | TNK2 | 1.05538273 |
| 39 | PDK1 | 1.05081104 |
| 40 | CAMK1D | 1.03632618 |
| 41 | JAK2 | 1.03275632 |
| 42 | MAP3K9 | 1.02441948 |
| 43 | HCK | 1.01040334 |
| 44 | GRK5 | 1.00022339 |
| 45 | ITK | 0.95379149 |
| 46 | FES | 0.93668478 |
| 47 | LYN | 0.93179457 |
| 48 | PAK2 | 0.89817433 |
| 49 | KIT | 0.89127342 |
| 50 | VRK1 | 0.88172292 |
| 51 | ADRBK2 | 0.83510499 |
| 52 | LCK | 0.82985068 |
| 53 | DDR2 | 0.81977144 |
| 54 | MAP3K11 | 0.79448712 |
| 55 | SYK | 0.77696411 |
| 56 | MAP3K1 | 0.77554393 |
| 57 | ABL2 | 0.74856082 |
| 58 | TAOK3 | 0.73377997 |
| 59 | CAMK1G | 0.73113752 |
| 60 | SIK2 | 0.70075473 |
| 61 | PDPK1 | 0.69620312 |
| 62 | RIPK1 | 0.69136647 |
| 63 | MAP2K3 | 0.65894964 |
| 64 | IKBKE | 0.65339307 |
| 65 | PTK6 | 0.65103931 |
| 66 | EPHB2 | 0.63813565 |
| 67 | PIK3CG | 0.62839268 |
| 68 | IGF1R | 0.62035481 |
| 69 | MAPKAPK2 | 0.59372983 |
| 70 | EIF2AK2 | 0.58995366 |
| 71 | MAPKAPK5 | 0.58599266 |
| 72 | NME2 | 0.58269285 |
| 73 | CAMKK1 | 0.57831869 |
| 74 | MAP3K5 | 0.57768296 |
| 75 | BTK | 0.56390922 |
| 76 | TRIM28 | 0.55907944 |
| 77 | CDK6 | 0.55736493 |
| 78 | MAP2K6 | 0.53895389 |
| 79 | EEF2K | 0.53356209 |
| 80 | FLT3 | 0.52040776 |
| 81 | CDK3 | 0.52000245 |
| 82 | TEC | 0.50900069 |
| 83 | CAMKK2 | 0.50046924 |
| 84 | DMPK | 0.48921140 |
| 85 | PRKCQ | 0.48742897 |
| 86 | CAMK4 | 0.48292269 |
| 87 | PDGFRB | 0.47419563 |
| 88 | GRK1 | 0.47250221 |
| 89 | MAP3K6 | 0.46780365 |
| 90 | MAP2K4 | 0.45703309 |
| 91 | IRAK2 | 0.44487228 |
| 92 | OXSR1 | 0.43732535 |
| 93 | MAP3K2 | 0.43690048 |
| 94 | IRAK1 | 0.41957874 |
| 95 | SGK3 | 0.41595517 |
| 96 | INSR | 0.41449641 |
| 97 | PKN1 | 0.41144958 |
| 98 | RPS6KA2 | 0.39764871 |
| 99 | GSK3A | 0.39597550 |
| 100 | PRKACG | 0.38634966 |
| 101 | MAPK4 | 0.38168611 |
| 102 | TESK2 | 0.36911392 |
| 103 | EGFR | 0.36298846 |
| 104 | CHUK | 0.36265844 |
| 105 | SGK2 | 0.35693659 |
| 106 | PRKD1 | 0.35521758 |
| 107 | FGR | 0.35157248 |
| 108 | STK3 | 0.33788336 |
| 109 | MAP2K2 | 0.33550513 |
| 110 | ERBB2 | 0.31278995 |
| 111 | ERBB3 | 0.31275276 |
| 112 | STK11 | 0.30725930 |
| 113 | PRKAA2 | 0.29691812 |
| 114 | RET | 0.28989687 |
| 115 | SRC | 0.27350918 |
| 116 | HIPK2 | 0.27246016 |
| 117 | ADRBK1 | 0.26729282 |
| 118 | CASK | 0.26520066 |
| 119 | CDK8 | 0.26402267 |
| 120 | RPS6KL1 | 0.26174180 |
| 121 | RPS6KC1 | 0.26174180 |
| 122 | ARAF | 0.25145889 |
| 123 | RPS6KA6 | 0.24376943 |
| 124 | MAP3K10 | 0.23884800 |
| 125 | MARK3 | 0.23410836 |
| 126 | PRKG1 | 0.20489006 |
| 127 | MAPKAPK3 | 0.19785344 |
| 128 | FYN | 0.19086957 |
| 129 | ABL1 | 0.19012958 |
| 130 | MAP3K13 | 0.18352163 |
| 131 | PRKCD | 0.16194714 |
| 132 | FGFR3 | 0.15908553 |
| 133 | YES1 | 0.15847416 |
| 134 | CDK9 | 0.15676915 |
| 135 | PRKG2 | 0.11212288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.29993715 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.48049047 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.30160661 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 4.14365626 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.53083579 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 3.03932603 |
| 7 | Asthma_Homo sapiens_hsa05310 | 3.00113006 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.62297638 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.58031206 |
| 10 | Prion diseases_Homo sapiens_hsa05020 | 2.27504857 |
| 11 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.24839442 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.15833401 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.12085080 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04143409 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01642121 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68951534 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61513742 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59893291 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54810897 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54214261 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49509461 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.45965211 |
| 23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42621046 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41106498 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.34685126 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29971971 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28549586 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.27359803 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26918492 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12172848 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12045140 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08600272 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04185294 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.03063657 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02160190 |
| 36 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.02020787 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00497363 |
| 38 | Measles_Homo sapiens_hsa05162 | 0.96034461 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90383926 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89801369 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89749609 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87157412 |
| 43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84179298 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 0.80704603 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78808040 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.78271521 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77321718 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75032510 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74938599 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 0.74845340 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74401541 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73624440 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.72615425 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.69538382 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69261099 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68275719 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.67795689 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67391260 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67390194 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64161612 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63783255 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63112910 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63036372 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62337011 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.61452604 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60979074 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60375834 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59054861 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58646757 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.56297392 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56239709 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55348686 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54906018 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54773647 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54036736 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52110845 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51269065 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.51159317 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50855458 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50667859 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.50131637 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.49800123 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48970671 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47773443 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47118697 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46902791 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46016865 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45904610 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44825286 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41406205 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.41290839 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40183830 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39974901 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39203343 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39060776 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.38940786 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36777496 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36540049 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35856164 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35538385 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35345925 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34308691 |
| 103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.34253195 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33945762 |
| 105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31399669 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31036813 |
| 107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29695120 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29456310 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28619641 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28379312 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27868279 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27447317 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.27193285 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26781487 |
| 115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.26733677 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26366029 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25890031 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25208165 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25054730 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24961738 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.24651435 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24572844 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22147526 |
| 124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.21387741 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18591421 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16743848 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16549101 |
| 128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.14739822 |
| 129 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.14125300 |
| 130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.13829577 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13297196 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12445731 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12387256 |

